Mineralocorticoid receptor antagonists and prevention of atrial fibrillation in patients with hypertension. Authors' reply.

Autor: Mujović N; Cardiology Clinic, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia. nmujovic@gmail.com, Marinković M; Cardiology Clinic, Clinical Center of Serbia, Belgrade, Serbia, Mihajlović M; Faculty of Medicine, University of Belgrade, Belgrade, Serbia, Mujović N; Clinic for Physical Medicine and Rehabilitation, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia, Potpara TS; Cardiology Clinic, Clinical Center of Serbia, Belgrade, Serbia; Clinic for Physical Medicine and Rehabilitation, Clinical Center of Serbia, Belgrade, Serbia
Jazyk: angličtina
Zdroj: Kardiologia polska [Kardiol Pol] 2020 Jun 25; Vol. 78 (6), pp. 610-611. Date of Electronic Publication: 2020 Jun 25.
DOI: 10.33963/KP.15453
Databáze: MEDLINE